🇺🇸 FDA
Patent

US 10561673

Dendrimer based nanodevices for therapeutic and imaging purposes

granted A61KA61K31/198A61K31/405

Quick answer

US patent 10561673 (Dendrimer based nanodevices for therapeutic and imaging purposes) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/198, A61K31/405, A61K31/43, A61K31/57